Binding of transcription factors NF-κB and STAT3 to promoters of key proliferative genes such as cyclin D1 and c-Myc, in combination with ERα, provided the basis for estradiol-independent, non-canonical proliferation of ER+ breast cancer cells. The gene discussed is ESR1; the disease is breast cancer.